| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:02 | Bullion Gold Resources Corporation: Bonanza Gold Intercept from Phase 2 Drilling at Bousquet | 196 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 23, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") is pleased to announce first assay results from the Phase 2 drilling... ► Artikel lesen | |
| 05.03. | Bullion Gold Resources Corp (2): Bullion Gold plans 25,000 m drill program at Terragold | 3 | Stockwatch | ||
| 05.03. | Bullion Gold Resources Corporation: Bullion Gold Plans a 25,000 M Drilling Program on Its Terragold Project | 385 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 5, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is currently preparing an application for a forestry intervention... ► Artikel lesen | |
| 26.02. | Bullion Gold Resources Corporation: Bullion Gold Obtains Drilling Permits for the Langlade Project | 332 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 26, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has received approval from the Quebec Ministry... ► Artikel lesen | |
| 17.02. | Bullion Gold Resources Corporation: Diamond Drilling Intersects Multiple Visible Gold Occurrences at the Bousquet Gold Project | 507 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 17, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") and it's partner Olympio Metals are pleased to announce that the... ► Artikel lesen | |
| 13.02. | Bullion Gold Resources Corp (2): Bullion Gold restarts drilling at Bousquet project | 1 | Stockwatch | ||
| 12.02. | Bullion Gold Resources Corporation: Drilling Resumes at Bousquet Gold Project, Quebec | 303 | Newsfile | Montréal, Québec--(Newsfile Corp. - February 12, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that it's partner Olympio Metals ("Olympio")... ► Artikel lesen | |
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 12.02. | XFRA NEW INSTRUMENTS AVAILABLE ON 12.02.2026 | 343 | Xetra Newsboard | The following instruments on XETRA do have their first trading 12.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.02.2026
Aktien
1 CA13723D1006 Canasil Resources Inc.
2... ► Artikel lesen | |
| 03.02. | Bullion Gold Resources Corp (2): Bullion Gold acquisition of Abitibi mining claims | 1 | Stockwatch | ||
| 27.01. | Bullion Gold Resources Corp (2): Bullion Gold takes 100% ownership of Terragold | 2 | Stockwatch | ||
| 26.01. | Bullion Gold Resources Corporation: Bullion Gold Acquires 100% of the Terragold Project and Consolidates a Strategic Gold Asset | 306 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 26, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the signing of an amendment to the original... ► Artikel lesen | |
| 09.01. | Bullion Gold Resources Corp (2): Bullion Gold private placement | 2 | Stockwatch | ||
| 06.01. | Bullion Gold Resources Corporation: High-Grade Gold up to 12.2 g/t Intersected in Multiple Structures at Bousquet | 543 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 6, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") is pleased to announce further assay results for the Bousquet... ► Artikel lesen | |
| 24.12.25 | Bullion Gold Resources Corp (2): Bullion Gold closes $300,000 private placement | 2 | Stockwatch | ||
| 23.12.25 | Bullion Gold Resources Corporation: Bullion Gold Completes Private Placement | 428 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 23, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has closed a private placement (the "Offering")... ► Artikel lesen | |
| 02.12.25 | Bullion Gold Resources Corporation: Bullion Gold Presents the Historical Overview of Its Terragold Gold Project | 436 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 2, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Corporation") will soon file an ATI permit application for a stripping and drilling... ► Artikel lesen | |
| 26.11.25 | Bullion Gold Resources Corporation: Bullion Gold Acquires the Transterre, Transterre-Ouest, and Candore Gold Projects (Forming the Terragold Project) | 511 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 26, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Corporation") is pleased to announce the signing of an acquisition agreement... ► Artikel lesen | |
| 14.11.25 | Bullion Gold Resources Corp (2): Bullion begins survey at Langlade, appoints director | 1 | Stockwatch | ||
| 13.11.25 | Bullion Gold Resources Corporation: Bullion Gold Begins Geochemical Survey of Base Till on Langlade and Appoints a New Director to Its Board | 503 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 13, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") is proud to announce the launch of an intensive follow-up program... ► Artikel lesen | |
| 29.10.25 | Bullion Gold Resources Corp (2): Bullion Gold private placement | 1 | Stockwatch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 34,515 | -2,10 % | Qiagen unter Druck, Zalando auf Erholungskurs: DAX-Ausblick | Der DAX befindet sich weiter auf Talfahrt. In der abgelaufenen Woche büßte das größte deutsche Börsenbarometer rund 144 Punkte ein und schloss -0,61% niedriger mit 23.447 Punkten. Die höchsten Verluste... ► Artikel lesen | |
| BIONTECH | 77,00 | -0,13 % | Übernahmekandidat BioNTech? Was läuft bei CHAR Technologies und Steyr Motors? | Eine Clean-Tech-Wachstumsstory mit Übernahmefantasie gibt es derzeit für nur rund 35 Mio. CAD. CHAR Technologies profitiert mit seiner Technologie von den steigenden Preisen für Öl und Gas. Steigt die... ► Artikel lesen | |
| VALNEVA | 2,854 | -36,86 % | Valneva: Nettoverlust wegen Sondereffekt vervielfacht - Lyme-Daten entscheidend | Der Impfstoffhersteller Valneva hat im Geschäftsjahr 2025 einen Nettoverlust von 115,2 Millionen Euro ausgewiesen, nach einem Verlust von 12,2 Millionen Euro im Vorjahr. Der Vergleich ist jedoch durch... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 80,04 | +20,98 % | Morning Market Movers: urban-gro, WeShop Holdings, QVC Group, Apogee Therapeutics See Big Swings | OTTAWA (dpa-AFX) - At 8:30 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| EVOTEC | 4,222 | -2,04 % | Aluminium, Kupfer und Arzneimittel! Alcoa, Power Metallic Mines, Evotec | Lange hat sich die italienische Unicredit Bank davor gescheut, ein offizielles Übernahmeangebot gegenüber der deutschen Commerzbank abzugeben. Wenngleich der sukzessive Zukauf an Geschäftsanteilen ein... ► Artikel lesen | |
| BIOAFFINITY TECHNOLOGIES | 4,470 | +64,34 % | What's Going On With bioAffinity Stock Thursday? | ||
| BB BIOTECH | 47,300 | -4,54 % | HV-Termine: Hauptversammlungen bei All for One, BB Biotech, MeVis, Novo Nordisk, Sartorius | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| ARCELLX | 114,50 | -0,26 % | Laufende Fusionskontrollverfahren: Gilead Sciences, Foster City, CA/USA; Erwerb sämtlicher Anteile an und Kontrolle über die Arcellx, Redwood City, CA/USA | Datum der Anmeldung:13.03.2026Aktenzeichen:B3-41/26Unternehmen:Gilead Sciences, Foster City, CA/USA; Erwerb sämtlicher Anteile an und Kontrolle über die Arcellx, Redwood City, CA/USAProduktmärkte:Hämatologie... ► Artikel lesen | |
| STRUCTURE THERAPEUTICS | 49,790 | +2,62 % | Structure Therapeutics Inc.: Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron | Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral... ► Artikel lesen | |
| TYRA BIOSCIENCES | 36,850 | -0,81 % | Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights | - Launched "dabogratinib 3x3" strategy to pursue 3 late-stage clinical studies in LG-UTUC, IR NMIBC and ACH, 3 potential blockbuster indications -
- Interim Ph2... ► Artikel lesen | |
| CG ONCOLOGY | 64,52 | -0,83 % | CG Oncology Inc.: CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates | PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in intermediate-risk NMIBC expected first half 2026CORE-008 Cohort CX Phase 2 first results of combination... ► Artikel lesen | |
| DAY ONE BIOPHARMACEUTICALS | 21,360 | 0,00 % | Weekly Buzz: Bristol Myers Squibb Wins FDA Nod; EU Okays Johnson & Johnson's AKEEGA; Ipsen Withdraws Tazverik, Day One Biopharmaceuticals Acquired | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed key FDA approvals, EU approvals, IND clearances, acquisitions, and clinical trial data readouts across key therapeutic areas... ► Artikel lesen | |
| COGENT BIOSCIENCES | 35,020 | +4,79 % | Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application | ||
| VERA THERAPEUTICS | 39,950 | -1,72 % | Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer | BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments... ► Artikel lesen | |
| TERNS PHARMACEUTICALS | 43,600 | +0,93 % | Terns Pharmaceuticals, Inc.: Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | FOSTER CITY, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage oncology company, today announced the closing of its... ► Artikel lesen |